Simvastatin and Ezetimibe Combination Fights High Cholesterol in Kidney Disease Patients

by Dr. Nithin Jayan on  August 11, 2011 at 12:30 PM Health Watch
RSS Email Print This Page Comment bookmark
Font : A-A+

A drug combination that lowers blood cholesterol has been found to reduce ailments of the heart in patients suffering from kidney disease.
Simvastatin and Ezetimibe Combination Fights High Cholesterol in Kidney Disease Patients
Simvastatin and Ezetimibe Combination Fights High Cholesterol in Kidney Disease Patients

Chronic Kidney Disease (CKD) is a condition that causes slow loss of kidney function over time, taking months or years to develop. CKD is associated with an increased risk of heart disease; yet prevention of heart disease in patients with CKD continues to be a less researched area.

Increased cholesterol levels serve as the prime cause for vascular events that ultimately result in heart disease. LDL cholesterol or 'bad cholesterol' is the worst agent responsible for the pathology. A number of drugs are available to fight high cholesterol levels. Statins are the most effective drugs available for reducing LDL levels, and work by inhibiting key enzymes in the synthesis of LDL. Simvastatin is a commonly used statin. Another drug called ezetimibe, which aids in fighting bad cholesterol, works by inhibiting the absorption of cholesterol in the small intestine.

A recent study evaluated the use of a combination of simvastatin and ezetimibe in patients with chronic kidney disease. Results were published in the Lancet, a leading medical journal. The trial known as SHARP (Study of Heart and Renal Protection) aimed at assessing the safety and efficacy of reducing LDL cholesterol in more than 9000 patients with chronic kidney disease.

Researchers concluded that simvastatin 20 mg plus ezetimibe 10 mg daily in patients with advanced chronic kidney disease reduced the incidence of angioplasty or and of major diseases affecting the heart or blood vessels such as heart attack (myocardial infarction) and stroke. Though the study results are not totally conclusive, a great significance can be attached to it. A reduction in heart disease complications in high risk patients like those with chronic kidney disease is definitely desirable.

Source: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial; Colin Baigent et al;The Lancet, Volume 377, Issue 9784, Pages 2181 - 2192, 25 June 2011.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Cholesterol High Cholesterol Heart Attack Urinary Stones In Children Vesico-Ureteric Reflux Causing UTI in Children Hydronephrosis / Antenatal Counseling Diet Lifestyle and Heart Disease Body Mass Index Kidney Disease Cholesterol - The Enigma Chemical 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive